NRP1 and COVID-19: Disease transmission in asymptomatic subjects may be affected by manipulating the VEGF-A165a subtype/b1 domain of neuropilin-1 (NRP-1) signaling, which is upregulated at the transcriptional level in COVID-19 [122].